T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 06/30/2016
Domestic Stock 56.6%
Domestic Bond 20.7%
Cash 14.2%
Foreign Bonds 4.5%
Foreign Stock 3.2%
Preferreds 0.9%
Convertibles 0.9%
Options -0.5%
Volatility and Other Measures
as of 06/30/2016
Beta 0.64
0.94
Standard Deviation 7.33
Price/Earnings Ratio (Domestic) 19.1
Earnings Growth Rate (Domestic) 11.2
Turnover Rate 26.9
Median Market
Capitalization
$42,818.78 Million
Sector Diversification
as of 06/30/2016
% of Total Net Assets
Health Care 18.2%
Financials 12.6%
Information Technology 8.2%
Consumer Discretionary 7.4%
Industrials & Business Services 5.6%
Consumer Staples 5.1%
Utilities 1.6%
Telecommunication Services 0.7%
Materials 0.6%
Energy 0.6%
10 Largest Holdings
Represents 25.73 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
AutoZone
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Marsh & McLennan
Microsoft
Thermo Fisher Scientific
Tyco International
Willis Group Holdings
As of 06/30/2016 the Capital Appreciation Fund had a total of 268 holdings.
See Glossary for additional details on all data elements.